Found: 59
Select item for more details and to access through your institution.
ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations.
- Published in:
- Scientific Reports, 2015, p. 11392, doi. 10.1038/srep11392
- By:
- Publication type:
- Article
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41774-w
- By:
- Publication type:
- Article
PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non‐small cell lung cancer.
- Published in:
- Cell Proliferation, 2022, v. 55, n. 9, p. 1, doi. 10.1111/cpr.13283
- By:
- Publication type:
- Article
Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14521, doi. 10.3390/ijms241914521
- By:
- Publication type:
- Article
A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10905-3
- By:
- Publication type:
- Article
Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231187205
- By:
- Publication type:
- Article
Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231179315
- By:
- Publication type:
- Article
EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 2012, v. 83, n. 5, p. 248, doi. 10.1159/000341381
- By:
- Publication type:
- Article
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01150-4
- By:
- Publication type:
- Article
Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer.
- Published in:
- Oncology Letters, 2017, v. 13, n. 4, p. 2425, doi. 10.3892/ol.2017.5740
- By:
- Publication type:
- Article
IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 9, p. 1, doi. 10.1002/ctm2.1354
- By:
- Publication type:
- Article
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2).
- Published in:
- BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02470-6
- By:
- Publication type:
- Article
Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1145303
- By:
- Publication type:
- Article
Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers.
- Published in:
- Frontiers in Oncology, 2023, v. 12, p. 1, doi. 10.3389/fonc.2022.1099304
- By:
- Publication type:
- Article
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 13, p. 1050, doi. 10.1111/1759-7714.15295
- By:
- Publication type:
- Article
Screening for depression and anxiety in lung cancer patients: A real‐world study using GAD‐7 and HADS.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 13, p. 1041, doi. 10.1111/1759-7714.15287
- By:
- Publication type:
- Article
Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 5, p. 419, doi. 10.1111/1759-7714.15209
- By:
- Publication type:
- Article
Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 34, p. 3421, doi. 10.1111/1759-7714.15157
- By:
- Publication type:
- Article
Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppressive tumor immune microenvironment.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 19, p. 1843, doi. 10.1111/1759-7714.14929
- By:
- Publication type:
- Article
Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer: An updated systematic review and meta‐analysis
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 22, p. 3124, doi. 10.1111/1759-7714.14664
- By:
- Publication type:
- Article
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non–small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2951, doi. 10.1111/1759-7714.14635
- By:
- Publication type:
- Article
Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 23, p. 3273, doi. 10.1111/1759-7714.14133
- By:
- Publication type:
- Article
Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 20, p. 2732, doi. 10.1111/1759-7714.14114
- By:
- Publication type:
- Article
Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0110780
- By:
- Publication type:
- Article
Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0051021
- By:
- Publication type:
- Article
Detection and Clinical Significance of Intratumoral <i>EGFR</i> Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0054170
- By:
- Publication type:
- Article
Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions.
- Published in:
- Frontiers of Medicine, 2023, v. 17, n. 1, p. 18, doi. 10.1007/s11684-022-0976-4
- By:
- Publication type:
- Article
Mechanism of Platinum Derivatives Induced Kidney Injury.
- Published in:
- Chinese Journal of Lung Cancer, 2015, v. 18, n. 9, p. 580, doi. 10.3779/j.issn.1009-3419.2015.09.09
- By:
- Publication type:
- Article
Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non–Small Cell Lung Cancer: A Phase 1 Trial.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2013770, doi. 10.1001/jamanetworkopen.2020.13770
- By:
- Publication type:
- Article
Complete response induced by anti–PD‐1‐based immunotherapy with toripalimab in a patient with locally advanced lung adenocarcinoma who failed rapidly after concurrent chemoradiotherapy: A case report.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 6, p. 1511, doi. 10.1111/jcpt.13248
- By:
- Publication type:
- Article
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45361-5
- By:
- Publication type:
- Article
Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 1, p. 66, doi. 10.1111/1759-7714.13711
- By:
- Publication type:
- Article
Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 1, p. 30, doi. 10.1111/1759-7714.13685
- By:
- Publication type:
- Article
Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID‐19 epidemic.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1752, doi. 10.1111/1759-7714.13424
- By:
- Publication type:
- Article
Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 5, p. 1149, doi. 10.1111/1759-7714.13356
- By:
- Publication type:
- Article
Pegylated recombinant human granulocyte colony‐stimulating factor regulates the immune status of patients with small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 713, doi. 10.1111/1759-7714.13322
- By:
- Publication type:
- Article
Prognostic significance of molecular characteristics of cerebrospinal fluid for non‐small cell lung cancer patients with leptomeningeal metastasis.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 8, p. 1673, doi. 10.1111/1759-7714.13123
- By:
- Publication type:
- Article
Impact of PD‐L1, transforming growth factor‐β expression and tumor‐infiltrating CD8<sup>+</sup> T cells on clinical outcome of patients with advanced thymic epithelial tumors.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 11, p. 1341, doi. 10.1111/1759-7714.12826
- By:
- Publication type:
- Article
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 9, p. 1166, doi. 10.1111/1759-7714.12819
- By:
- Publication type:
- Article
Efficacy and safety of weekly intravenous nanoparticle albumin-bound paclitaxel for non-small cell lung cancer patients who have failed at least two prior systemic treatments.
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 3, p. 138, doi. 10.1111/1759-7714.12413
- By:
- Publication type:
- Article
High-fidelity of non-small cell lung cancer xenograft models derived from bronchoscopy-guided biopsies.
- Published in:
- Thoracic Cancer, 2016, v. 7, n. 1, p. 100, doi. 10.1111/1759-7714.12291
- By:
- Publication type:
- Article
Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 3, p. 269, doi. 10.1111/1759-7714.12177
- By:
- Publication type:
- Article
Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 3, p. 319, doi. 10.1111/1759-7714.12204
- By:
- Publication type:
- Article
Patients harboring epidermal growth factor receptor ( EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors.
- Published in:
- Thoracic Cancer, 2014, v. 5, n. 2, p. 126, doi. 10.1111/1759-7714.12068
- By:
- Publication type:
- Article
The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI.
- Published in:
- Thoracic Cancer, 2012, v. 3, n. 4, p. 334, doi. 10.1111/j.1759-7714.2012.00133.x
- By:
- Publication type:
- Article
Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2599, doi. 10.1007/s00262-020-02642-4
- By:
- Publication type:
- Article
Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5649, doi. 10.3390/cancers14225649
- By:
- Publication type:
- Article